|
National Stock Number(NSN): 6505-01-300-5490 (6505013005490, 013005490)
| NIIN: |
01-300-5490 |
Item Name: |
NAFCILLIN FOR INJECTION |
INC: |
66681
|
| FSC: |
6505
|
Assignment Date: |
May-16-1989 |
CRIT: |
X |
IIG: |
66681 |
| ISC: |
5 |
Date Standardized: |
May-16-1989 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
U |
FIIG: |
A34300 |
| ESD: |
|
Schedule B: |
3004.90.9290 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
ADD-VANTAGE |
04683
|
KING PHARMACEUTICALS INC |
H |
5 |
1 |
6 |
54 |
|
|
|
|
|
|
|
NALLPEN |
04683
|
KING PHARMACEUTICALS INC |
H |
5 |
1 |
6 |
54 |
|
|
|
|
|
|
|
NDC00029-6374-40 |
04683
|
KING PHARMACEUTICALS INC |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AGXW |
PHYSICAL FORM |
POWDER |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
2.000 GRAMS NAFCILLIN SODIUM ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
2.000 GRAMS OF ACTIVE INGREDIENT |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
1 |
| CSGS |
ADMINISTRATION |
INTRAMUSCULAR AND INTRAVENOUS |
| FEAT |
SPECIAL FEATURES |
BUFFERED |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|